This is the University of Michigan Nephrology Research BioBank, an observational research resource rather than a treatment trial. Participants' clinical information, blood, and urine are collected; when a kidney biopsy is already performed for clinical care, a remaining sample can be reserved after diagnostic requirements are met. Researchers use the material to investigate molecular and genetic features of kidney disease. 12

The inspected registry version, updated April 18, 2025, listed 420 estimated participants and a recruiting status. That is a projected enrollment and a dated registry statement, not confirmation that 420 people were enrolled or that participation is available today. 12

Its intended contribution is better understanding of disease mechanisms and potential biomarkers. The record does not demonstrate that joining the biobank improves kidney function or that a new diagnostic marker has already been clinically validated. 12